Bill > HB4409

This bill, known as the "Drug Manufacturer Data Reporting Act," requires drug manufacturers to report certain information to the Michigan Department of Insurance and Financial Services, including increases in the wholesale acquisition cost of prescription drugs, the costs of researching and developing new drugs, and the introduction of new high-cost prescription drugs to the market. The bill also requires the department to prepare an annual report based on the information received and publish it on the department's website. The bill exempts the reports and information received from drug manufacturers from public disclosure and imposes civil fines for violations.